Completed
RNA Disruption Assay (RDA) Response Prediction in Neoadjuvant Chemotherapy Breast Cancer Treatment
NCT02190227
- Conditions
- Breast Diseases, Breast Neoplasms, Invasive Breast Cancer, +4 more
- Locations
-
- Jewish General Hospital Montreal, Quebec, Canada